GO:0042938 dipeptide transport: Nutrient Uptake Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042938 dipeptide transport describes the directed movement of a dipeptide, two amino acids joined by a peptide bond, into, out of or within a cell, or between cells, via transporters or pores.
• Dipeptide transport is a distinct biological process from free amino acid transport and is mediated by dedicated solute carrier (SLC) transporters and bacterial permeases.
• The orphan lysosomal solute carrier MFSD1 was recently shown to facilitate highly selective dipeptide transport, linking this process to lysosomal biology.
• In cancer, dipeptide transport systems sit at the interface of peptide metabolism and drug delivery, making them candidate targets for prodrug strategies.
• Dipeptide transport influences intestinal absorption, satiety signaling, and systemic peptide availability in animal models.
• Proteinogenic dipeptides are emerging as a class of small-molecule regulators in plants, expanding the functional scope of dipeptide transport beyond nutrient uptake.
Description
Dipeptide transport (GO:0042938) is the directed movement of a dipeptide, a combination of two amino acids linked by a peptide (-CO-NH-) bond, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. This process is fundamental to nitrogen and amino acid economy in organisms ranging from bacteria to mammals, and it operates alongside, but independently of, free amino acid transport systems. Because dipeptides can be absorbed more efficiently than equivalent free amino acids in some epithelia, dipeptide transport has long been studied in the context of intestinal physiology and nutrition. In recent years, the molecular identity of dipeptide transporters has expanded. The lysosomal solute carrier MFSD1 was identified as an orphan transporter that facilitates highly selective dipeptide transport, connecting this process to lysosomal degradation and metabolite export. In parallel, dipeptide transport systems have been recognized at the interface of peptide metabolism and drug delivery in cancer, where they can influence the uptake of peptidomimetic therapeutics. Proteinogenic dipeptides are also emerging as small-molecule regulators in plants, suggesting that dipeptide transport participates in signaling as well as nutrition. For researchers, GO:0042938 provides a precise ontology handle for annotating genes, interpreting transport assays, and designing CRISPR-based models. Understanding which transporters mediate dipeptide flux, how selectivity is achieved, and how transport is regulated is essential for studies of nutrient sensing, drug pharmacokinetics, and disease mechanisms.
dipeptide transport At A Glance
| GO ID | GO:0042938 |
|---|---|
| GO term | dipeptide transport |
| Ontology | biological_process |
| Synonym | none |
| Major function | Directed movement of a dipeptide into, out of or within a cell, or between cells, via a transporter or pore |
| Substrate | Dipeptide, a combination of two amino acids by means of a peptide (-CO-NH-) link |
| Representative transporters | MFSD1 (lysosomal SLC), bacterial dipeptide permeases, intestinal peptide transporters |
| Related processes | Peptide metabolism, amino acid homeostasis, drug delivery, nutrient sensing |
| Disease relevance | Cancer drug delivery, lysosomal storage and trafficking disorders, intestinal absorption defects |
What Is GO:0042938?
In our own words, dipeptide transport (GO:0042938) is the biological process by which a dipeptide, defined as two amino acids joined by a single peptide bond, is moved across a membrane or between cellular compartments. The movement is directed and mediated by a transporter or pore, and it can occur into a cell, out of a cell, within a cell, or between cells. This definition distinguishes dipeptide transport from the transport of single amino acids and from the intracellular trafficking of larger peptides or proteins.
Why Is dipeptide transport Important in Cell Biology?
Dipeptide transport is important because it governs how organisms capture, distribute, and sense small peptide nutrients, and because it directly affects the bioavailability of peptide-based drugs and prodrugs. In the intestine, dipeptide transport contributes to amino acid absorption and to satiety signaling after protein ingestion. In lysosomes, selective dipeptide transport by MFSD1 links peptide catabolism to metabolite export and cellular quality control. In bacteria, dipeptide permeases such as those in Salmonella typhimurium mediate uptake of dipeptide-like compounds including 5-aminolevulinic acid, illustrating the broad substrate scope of these systems. Because dipeptide transport sits at the crossroads of metabolism, signaling, and pharmacology, it is a high-value process for both basic and translational research.
• Dipeptide transport enables efficient absorption of amino acids in peptide form, complementing free amino acid transporters.
• It shapes systemic peptide availability and has been linked to satiety responses after ingestion of beta-lactoglobulin dipeptides and beta-casomorphin-7 metabolites.
• Lysosomal dipeptide transport by MFSD1 connects peptide degradation to metabolite export and lysosomal function.
• In cancer, dipeptide transport systems influence peptide metabolism and the cellular uptake of peptidomimetic drugs.
• Bacterial dipeptide permeases mediate uptake of non-standard substrates such as 5-aminolevulinic acid, with implications for antimicrobial and photodynamic strategies.
• Proteinogenic dipeptides act as small-molecule regulators in plants, indicating roles for dipeptide transport in signaling.
• Dipeptide transport is a determinant of oral bioavailability for peptide-based therapeutics.
• Membrane transporter biology, including dipeptide transport, is central to drug disposition and pharmacokinetics.
• Developmental changes in intestinal dipeptide transport have been documented in animal models, indicating stage-specific regulation.
• Studying dipeptide transport informs the design of CRISPR models for nutrient transport, drug uptake, and lysosomal disease.
What Happens During dipeptide transport?
Substrate recognition at the membrane
In simple terms: First, the transporter must recognize and bind a dipeptide at the membrane.
Dipeptide transport begins with recognition of a dipeptide substrate by a membrane-embedded transporter or pore. The substrate is defined as two amino acids joined by a peptide (-CO-NH-) bond, and the transporter must discriminate this dipeptide from free amino acids and larger peptides. In bacteria, dipeptide permeases can accept dipeptide-like molecules such as 5-aminolevulinic acid, showing that substrate recognition is not limited to canonical dipeptides. In mammals, intestinal and lysosomal transporters contribute to dipeptide recognition at the apical membrane and lysosomal membrane, respectively.
Translocation across the membrane
In simple terms: The bound dipeptide is then moved across the membrane through the transporter.
After binding, the dipeptide is translocated across the lipid bilayer via a conformational cycle of the transporter. This step is the defining event of GO:0042938, because the process requires directed movement by a transporter or pore. In the intestinal mucosa, dipeptide transport activity has been measured directly in developing rabbits, demonstrating that translocation occurs in intact epithelial tissue. In lysosomes, MFSD1 facilitates highly selective dipeptide transport, indicating that translocation can be tightly controlled by the transporter's structural features.
Release and intracellular fate of the dipeptide
In simple terms: Once inside, the dipeptide is released and can be used or further processed.
Following translocation, the dipeptide is released on the trans side of the membrane, where it enters cellular peptide pools. These pools can be hydrolyzed to free amino acids or used as signaling molecules. Proteinogenic dipeptides have been described as an emerging class of small-molecule regulators, suggesting that released dipeptides can have functions beyond nutrition. In cancer cells, intracellular dipeptide pools intersect with peptide metabolism and drug delivery pathways, which is why dipeptide transport systems are studied as determinants of prodrug activation.
Physiological integration: intestine, lysosome, and beyond
In simple terms: Dipeptide transport is integrated into whole-body nutrient handling and organelle function.
At the physiological level, dipeptide transport contributes to intestinal amino acid absorption and to postprandial signaling. In vitro transport studies of a beta-lactoglobulin dipeptide and beta-casomorphin-7 metabolites have linked dipeptide transport to satiety responses. In the lysosome, MFSD1-mediated dipeptide transport connects peptide catabolism to lysosomal export and cellular quality control. In bacteria, dipeptide permeases support uptake of dipeptide-like nutrients and xenobiotics, illustrating the broad physiological integration of this process.
Pharmacological dimension: dipeptide transport and drug delivery
In simple terms: Dipeptide transporters can also carry drug-like molecules into cells.
Because dipeptide transporters recognize peptide-like substrates, they can mediate the uptake of peptidomimetic drugs and prodrugs. Dipeptide transport systems are now discussed at the interface of peptide metabolism and drug delivery in cancer, where they may be exploited to improve tumor-selective drug uptake. General membrane transporter biology, including dipeptide transport, is a key determinant of drug absorption and disposition. This pharmacological dimension makes GO:0042938 relevant to both basic transport biology and therapeutic development.
Key Genes Involved in GO:0042938 dipeptide transport
The following genes and proteins have been experimentally linked to dipeptide transport or to the transport of dipeptide-like substrates, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MFSD1 | Orphan lysosomal solute carrier that facilitates highly selective dipeptide transport | Model for lysosomal dipeptide export and lysosomal biology |
| SLC15A family (peptide transporters) | Mammalian proton-coupled peptide transporters implicated in dipeptide and peptide transport | Intestinal absorption and drug delivery studies |
| Dpp permease genes (bacterial dipeptide permease) | Bacterial dipeptide permease mediating uptake of dipeptides and dipeptide-like substrates | Uptake of 5-aminolevulinic acid in Salmonella typhimurium |
| Intestinal peptide transport machinery | Mediates dipeptide transport across intestinal mucosa | Developmental studies in rabbits |
| Beta-lactoglobulin-derived dipeptide transport system | Transports a beta-lactoglobulin dipeptide and beta-casomorphin-7 metabolites | Satiety and food-derived peptide studies |
| Proteinogenic dipeptide regulators (plant) | Small-molecule regulators whose transport affects plant physiology | Plant signaling and peptide regulator research |
| Membrane transporter superfamily members | General membrane transporters that can move dipeptides | Drug disposition and pharmacokinetics |
| Cancer peptide metabolism genes | Interface of peptide metabolism and drug delivery | Cancer drug delivery and prodrug strategies |
| Lysosomal membrane protein network | Coordinates lysosomal transport and degradation | Lysosomal function and disease modeling |
| Intestinal epithelial transporters | Apical and basolateral transport of dipeptides | Nutrient absorption research |
| Bacterial peptide permeases | Broad-specificity uptake of peptide-like molecules | Antimicrobial and photodynamic research |
| Sarcoplasmic reticulum transport proteins | Transport processes in muscle sarcoplasmic reticulum | Historical muscle physiology studies |
| Peptide transporter regulatory proteins | Modulate transporter activity and expression | Regulation of dipeptide transport |
| Drug transporter interaction partners | Determine substrate selectivity for peptidomimetics | Pharmacological modeling |
| Lysosomal solute carrier interaction network | Supports selective dipeptide recognition | Structural and functional studies |
How Is dipeptide transport Regulated?
Dipeptide transport is regulated at multiple levels, including transporter expression, substrate availability, and developmental stage. In the intestinal mucosa of developing rabbits, dipeptide transport activity changes with age, indicating developmental regulation of this process. In cancer, dipeptide transport systems are discussed in the context of peptide metabolism and drug delivery, implying that transporter expression and activity can be modulated by the tumor microenvironment and metabolic state. General membrane transporter biology indicates that transporter activity is subject to regulation by cellular signals and substrate gradients. Lysosomal dipeptide transport by MFSD1 is selective, suggesting that substrate recognition and possibly transporter availability are controlled to match lysosomal degradation demands. Proteinogenic dipeptides as small-molecule regulators further suggest that dipeptide transport may be integrated with signaling pathways in plants.
dipeptide transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MFSD1 | Lysosomal dipeptide transport and lysosomal dysfunction | MFSD1 knockout and tagged knock-in cell lines for transport assays |
| SLC15A family | Intestinal absorption and drug delivery | Intestinal epithelial knockout and overexpression models |
| Dpp permease genes | Bacterial uptake of dipeptide-like substrates | Bacterial deletion mutants and substrate uptake assays |
| Beta-lactoglobulin dipeptide transport system | Satiety and food-derived peptide biology | In vitro transport and satiety assays |
| Cancer peptide metabolism genes | Tumor drug delivery and prodrug activation | Cancer cell knockout and overexpression models |
Dipeptide transport in cancer drug delivery
Dipeptide transport systems sit at the interface of peptide metabolism and drug delivery in cancer, where they can influence the uptake of peptide-based and peptidomimetic therapeutics. Because these transporters recognize dipeptide-like substrates, they are candidate mediators of tumor-selective prodrug activation. Understanding their expression and selectivity in cancer cells is therefore relevant to drug development and to predicting therapeutic response.
Lysosomal dysfunction and MFSD1
The lysosomal solute carrier MFSD1 facilitates highly selective dipeptide transport, linking this process to lysosomal function. Lysosomes are central to peptide degradation and metabolite export, and disruption of lysosomal transport can impair cellular quality control. MFSD1 therefore provides a molecular entry point for studying how defective dipeptide transport may contribute to lysosomal dysfunction and related disease states.
Intestinal absorption and nutritional disorders
Dipeptide transport in the intestinal mucosa is a route for amino acid absorption, and developmental changes in this process have been documented in rabbits. In vitro studies of a beta-lactoglobulin dipeptide and beta-casomorphin-7 metabolites have linked dipeptide transport to satiety responses, connecting this process to nutritional physiology. Defects in intestinal dipeptide transport could therefore affect nutrient handling and postprandial signaling, although specific human disorders require further study.
Bacterial dipeptide permeases and infection
Bacterial dipeptide permeases mediate the uptake of dipeptides and dipeptide-like molecules such as 5-aminolevulinic acid in Salmonella typhimurium. Because these permeases contribute to nutrient acquisition and to the uptake of non-standard substrates, they are relevant to bacterial physiology and to antimicrobial or photodynamic strategies that exploit dipeptide-like compounds. This makes bacterial dipeptide transport a potential target for intervention.
From dipeptide transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does MFSD1 mediate selective lysosomal dipeptide transport? | MFSD1 knockout and tagged knock-in cell lines |
| Which transporters mediate intestinal dipeptide absorption? | Intestinal epithelial knockout and overexpression models |
| Can dipeptide transporters be exploited for prodrug delivery in cancer? | Cancer cell knockout and overexpression models |
| How do bacterial dipeptide permeases recognize non-standard substrates? | Bacterial deletion mutants and point-mutation models |
| Do food-derived dipeptides require specific transporters for satiety effects? | In vitro transport and satiety assays with transporter knockdown |
| Are proteinogenic dipeptides transported as signaling molecules in plants? | Plant transporter knockout and overexpression lines |
How to Study the dipeptide transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Labeled dipeptide transport assay | Rate and selectivity of dipeptide uptake | Characterizing intestinal and lysosomal transporters |
| CRISPR knockout | Loss-of-function effects on dipeptide transport | Testing causal roles of candidate transporters |
| CRISPR knock-in (tagged) | Localization and interaction of transporters | Studying MFSD1 and other SLC transporters |
| Overexpression | Gain-of-function effects on transport capacity | Assessing transporter sufficiency |
| Bacterial uptake assay | Substrate specificity of dipeptide permeases | Studying 5-aminolevulinic acid uptake |
| In vitro satiety assay | Physiological response to transported dipeptides | Food-derived peptide research |
| Developmental transport profiling | Age-dependent changes in transport activity | Intestinal maturation studies |
| Pharmacological transport profiling | Drug-like substrate handling by transporters | Cancer drug delivery research |
Transport assays with labeled dipeptides
Direct measurement of dipeptide transport is typically performed using labeled or fluorescent dipeptide substrates in cultured cells or membrane vesicles. Such assays have been used to characterize intestinal dipeptide transport in developing rabbits and to study the transport of a beta-lactoglobulin dipeptide and beta-casomorphin-7 metabolites. In lysosomal studies, transport assays can be adapted to measure MFSD1-dependent dipeptide uptake.
Genetic perturbation and CRISPR screens
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of candidate dipeptide transporters. For example, MFSD1 knockout and tagged knock-in lines can be used to test selective dipeptide transport. In cancer research, CRISPR perturbation of peptide metabolism genes can reveal how dipeptide transport affects drug delivery. Bacterial deletion mutants of dipeptide permease genes provide a complementary system for substrate specificity studies.
Biochemical and structural characterization
Biochemical assays, including proteoliposome transport and substrate competition experiments, help define the selectivity of dipeptide transporters. The highly selective nature of MFSD1-mediated dipeptide transport was established through such approaches. In bacteria, uptake assays with 5-aminolevulinic acid demonstrated the substrate scope of the dipeptide permease. These methods are essential for linking transporter structure to function.
Physiological and pharmacological profiling
Physiological studies in animal models and in vitro satiety assays can connect dipeptide transport to whole-body responses. Developmental studies in rabbits documented changes in intestinal dipeptide transport, and in vitro transport and satiety studies linked a beta-lactoglobulin dipeptide to satiety responses. Pharmacological profiling of dipeptide transporters is also relevant to drug delivery in cancer.
How CRISPR Can Be Used to Study GO:0042938 dipeptide transport
Knockout
CRISPR knockout of candidate dipeptide transporter genes, such as MFSD1, provides a direct test of whether the gene is required for dipeptide transport. Knockout models can be used in cancer cells to assess the contribution of dipeptide transport to drug delivery and peptide metabolism. In bacteria, deletion of dipeptide permease genes can confirm their role in substrate uptake.
Point Mutation
CRISPR point mutation can be used to dissect the substrate-binding residues and selectivity filters of dipeptide transporters. Such models are valuable for understanding how MFSD1 achieves highly selective dipeptide transport. Point mutations in bacterial dipeptide permeases can also reveal determinants of non-standard substrate recognition, such as 5-aminolevulinic acid uptake.
Knock-in
CRISPR knock-in of epitope tags or fluorescent reporters allows visualization and biochemical isolation of dipeptide transporters. Tagged knock-in of MFSD1 supports studies of its lysosomal localization and transport function. Knock-in models can also be used to introduce disease-relevant variants or to monitor transporter expression in physiological contexts.
Overexpression
CRISPR-mediated overexpression or cDNA-based overexpression of dipeptide transporters increases transport capacity and can reveal gain-of-function phenotypes. Overexpression of candidate transporters in cancer cells can enhance uptake of peptidomimetic drugs, informing drug delivery strategies. Overexpression in intestinal or lysosomal models can also be used to study transport kinetics and substrate range.
How EDITGENE Supports dipeptide transport Research
Researchers studying dipeptide transport-related genes often need to determine whether a candidate gene is causally involved in dipeptide uptake, efflux, or intracellular distribution. Establishing causality requires clean genetic models that isolate the transporter of interest from related family members and from free amino acid transport pathways. EDITGENE provides CRISPR-based cell models and screening services designed to support such studies, from single-gene knockout to genome-wide library screening and bioinformatic analysis.
Contact EDITGENE today to design your custom CRISPR model for dipeptide transport research.
Frequently Asked Questions About dipeptide transport
What is dipeptide transport (GO:0042938)?
Dipeptide transport is the directed movement of a dipeptide, two amino acids joined by a peptide bond, into, out of or within a cell, or between cells, by means of a transporter or pore.
What genes are involved in dipeptide transport?
Genes and proteins linked to dipeptide transport include MFSD1, SLC15A family peptide transporters, bacterial dipeptide permeases, and intestinal peptide transport machinery.
Which transporter mediates selective lysosomal dipeptide transport?
The orphan lysosomal solute carrier MFSD1 facilitates highly selective dipeptide transport.
How is dipeptide transport studied experimentally?
Common approaches include labeled dipeptide transport assays, CRISPR knockout and knock-in models, bacterial uptake assays, and physiological profiling.
Why is dipeptide transport important in cancer?
Dipeptide transport systems sit at the interface of peptide metabolism and drug delivery in cancer, influencing the uptake of peptide-based therapeutics.
Does dipeptide transport occur in bacteria?
Yes, bacterial dipeptide permeases mediate uptake of dipeptides and dipeptide-like substrates such as 5-aminolevulinic acid in Salmonella typhimurium.
What is the difference between dipeptide transport and amino acid transport?
Dipeptide transport moves two amino acids joined by a peptide bond, whereas amino acid transport moves single amino acids; the two processes use distinct transporters.
Can dipeptide transporters be used for drug delivery?
Yes, because they recognize peptide-like substrates, dipeptide transporters are studied as mediators of peptidomimetic drug and prodrug uptake.
What role does dipeptide transport play in nutrition?
Intestinal dipeptide transport contributes to amino acid absorption and has been linked to satiety responses after ingestion of food-derived dipeptides.
Are proteinogenic dipeptides involved in signaling?
Proteinogenic dipeptides are emerging as a class of small-molecule regulators, suggesting roles in signaling beyond nutrition.
Conclusion
GO:0042938 dipeptide transport defines a distinct and biologically important process: the directed movement of two-amino-acid peptides across membranes by dedicated transporters or pores. Research spanning intestinal physiology, lysosomal biology, bacterial nutrient uptake, and cancer drug delivery has shown that dipeptide transport is integrated with metabolism, signaling, and pharmacology. The identification of selective transporters such as MFSD1 has provided new molecular handles for mechanistic studies. For researchers, dipeptide transport offers a tractable system for CRISPR-based causal genetics, from knockout and point mutation to knock-in and overexpression models. Combining these models with transport assays, screening, and bioinformatics will continue to clarify how dipeptide flux shapes nutrient handling, drug uptake, and disease.
References
- 1. Kim KH et al.. 2026. Dipeptide Transport Systems at the Interface of Peptide Metabolism and Drug Delivery in Cancer.. Int J Mol Sci 27(9) PMID: 42123314
- 2. Lee VH. 2000. Membrane transporters.. Eur J Pharm Sci 11 Suppl 2:S41-50 PMID: 11033426
- 3. Boytsov D et al.. 2024. Orphan lysosomal solute carrier MFSD1 facilitates highly selective dipeptide transport.. Proc Natl Acad Sci U S A 121(13):e2319686121 PMID: 38507452
- 4. Rubino A et al.. 1977. Dipeptide transport in the intestinal mucosa of developing rabbits.. Ciba Found Symp PMID: 244391
- 5. Osborne S et al.. 2014. In vitro transport and satiety of a beta-lactoglobulin dipeptide and beta-casomorphin-7 and its metabolites.. Food Funct 5(11):2706-18 PMID: 24892772
- 6. Minen RI et al.. 2023. Proteinogenic dipeptides, an emerging class of small-molecule regulators.. Curr Opin Plant Biol 75:102395 PMID: 37311365
- 7. Elliott T. 1993. Transport of 5-aminolevulinic acid by the dipeptide permease in Salmonella typhimurium.. J Bacteriol 175(2):325-31 PMID: 8380400
- 8. Boldyrev AA et al.. 1977. [Sarcoplasmic reticulum].. Usp Fiziol Nauk 8(3):48-73 PMID: 143148
